Data: 08/08/2026
Total encontrado: 18
1/18US=89 / Enfermagem
Shultz MK, Basche M. Cânceres gástrico, pancreático, hepatocelular e de vesícula biliar. In: Gates RA, Fink RM. Segredos em enfermagem oncológica: respostas necessárias ao dia-a-dia. 3ªed. São Paulo: Artmed, 2009. p. 278-89.

HELICOBACTER PYLORI; CANCER GASTRICO; GASTRECTOMIA; SINDROME DE DUMPING; PROCEDIMENTO DE WHIPPLE; SINAL DE COURVOISIER; HCC; SISTEMA OKUDA; QUIMIOEMBOLIZACAO TRANSARTERIAL; CARCINOMA HEPATOCELULAR; CANCER DE VESICULA; TUMOR DE KLATSKIN

2/18US=1 / Gastro
Thyparambil SP, Edmondson RD, Dragan YP. Primary liver cancer: chemical carcinogenesis. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 55-107. ISBN 978-1-60327-373-2.

CANCER PRIMARIO DE FIGADO; CARCINOGENESE QUIMICA; HCC; GENOTOXINAS

3/18US=1 / Gastro
Hann HWL, Feitelson M. Hepatocellular carcinoma associated with hepatitis B virus. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 235-57. ISBN 978-1-60327-373-2.

CARCINOMA HEPATOCELULAR; VIRUS DA HEPATITE B; HCC; HBV-DNA; HBV; HCV; HBSAG; HBEAG; HCC. PREVENCAO

4/18US=1 / Gastro
Masuzaki R, Yoshida H, Kato N, Omata M. Hepatitis C and hepatocellular carcinoma. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 259-81. ISBN 978-1-60327-373-2.

HEPATITE C; CARCINOMA HEPATOCELULAR; HCC. PREVENCAO

5/18US=1 / Gastro
Mehta G, Sass DA. Clinical features and a clinician's diagnostic approach to hepatocellular carcinoma. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 309-26. ISBN 978-1-60327-373-2.

CARCINOMA HEPATOCELULAR; TRIAGEM PARA HCC; PAPEL DA BIOPSIA HEPATICA; QUIMIOPREVENCAO DO HCC

6/18US=1 / Gastro
Carr BI, Nagalla S. Medial therapy of HCC. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 527-68. ISBN 978-1-60327-373-2.

TERAPIA MEDIAL DO HCC; SISTEMA TACE; INTRA-ARTERIAL

7/18US=1 / Gastro
Carr BI, Kralian S. Molecular targeted therapies for HCC. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 589-614. ISBN 978-1-60327-373-2.

TERAPIAS MOLECULAR PARA O HCC; ANGIOGENESE; CICLO CELULAR; ORAIS NOVOS AGENTES; COMBINACOES

8/18US=1 / Gastro
Carr BI, Marsh JW, Geller DA. Putting it all together. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 713-20. ISBN 978-1-60327-373-2.

TRIAGEM PARA HCC; PAPEL DA BIOPSIA; DOENCA METASTATICO; LESOES HEPATICAS; CIRROSE

9/18US=11 / Gastro
Masuzaki R, Omata M. HCC screening and surveillance. In: Al Knawy B, Reddy R, Bolondi L. Hepatocellular carcinoma: a practical approach. New York: Informa Healthcare, 2009. p. 26-35. ISBN 978-0415748080-2.

CARCINOMA HEPATOCELULAR; TRIAGEM; VIGILANCIA; POPULACAO-ALVO; METODOLOGIA DE VIGILANCIA

10/18US=11 / Gastro
Freeman RB. Liver transplantation as treatment for HCC. In: Al Knawy B, Reddy R, Bolondi L. Hepatocellular carcinoma: a practical approach. New York: Informa Healthcare, 2009. p. 146-56. ISBN 978-0415748080-2.

CARCINOMA HEPATOCELULAR. TRATAMENTO; TRANSPLANTE HEPATICO; DOADOR DE FIGADO

11/18US=60 / Biol/Mol
Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE

12/18US=96 / Biol/Mol
Carruba G. Aromatase in nontumoral and malignant human liver tissues and cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 187-93. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

AREG; HCC; ER; AROMATASE; ESTROGENIO; FIGADO; METABOLISMO; AMPHIREGULIN; CARCINOMA HEPATOCELULAR; RECEPTOR DE ESTROGENO

13/18US=96 / Biol/Mol
Miceli V, Cervello M, Azzolina A, Montalto G, Calabrò M, Carruba G. Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 252-6. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ARO; AREG; HCC; ER; AROMATASE; AMPHIREGULIN; CARCINOMA HEPATOCELULAR HUMANO; RECEPTOR DE ESTROGENO

14/18US=96 / Biol/Mol
Cusimano A, Foderà D, Lampiasi N, Azzolina A, Notarbartolo M, Giannitrapani L, D'Alessandro N, Montalto G, Cervello M. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 300-8. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

HCC; EP RECEPTORES; COX-1; COX-2; NSAIDS; HEPATOCELLULAR CARCINOMA

15/18US=23-D / Câncer
Lu SN, Wang JH, Kee KM, Tseng PL. Screening with ultrasonography of patients at high-risk for hepatocellular carcinoma: thrombocytopenia as a valid surrogate of cirrhosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 137-44. ISBN 978-1-4020-9803-1.

EPIDEMIOLOGIA DO CARCINOMA HEPATOCELULAR; EPIDEMIOLOGIA DA CIRROSE HEPATICA; BENEFICIO DO RASTREIO HCC; CIRROSE HEPATICA. TESTES DE SUBSTITUICAO; FRIBOSIS. ESTES DE SUBSTITUICAO; RASTREIO HCC ECOGRAFICA. ADULTO TROMBOCITOPENICA

16/18US=47 / Clín/Medica
Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 228-36. ISBN 978-1-57331-699-5.

HORMONIOS SEXUAIS. RISCO DE TUMOR NO FIGADO; TUMORES BENIGNOS DO FIGADO; HCC; ESTROGENIOS; ANDROGENOS; AROMATASE

17/18US=47 / Clín/Medica
Granata OM, Cocciadiferro L Miceli V, Polito LM, Campisi I, Carruba G. Metabolic profiles of androgens in malignant human liver cell lines. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 262-7. ISBN 978-1-57331-699-5.

EST; ANDROGRENES 5X; ANDROGENES 5B; CELULAS HCC; METABOLICOS DE ANDROGENOS; CELULAS DE FIGADO HUMANO MALIGNO; LINHAS DE AROMATASE

18/18US=782 / Tese/FAP
Silva MG. Avaliação da difusão por ressonância magnética na caracterização de lesões hepáticas em pacientes portadores de hepatocarcinoma. [Evaluation of diffusion by magnetic resonance imaging in characterization of hepatic lesions in patients with hepatocarcinoma]. São Paulo, 2019. 66 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2019/MGSilva/MGSilva.pdf

Curriculum Lattes

CARCINOMA HEPATOCELULAR; IMAGEM DE DIFUSAO POR RESSONANCIA MAGNETICA. METODOS; NEOPLASIAS HEPATICAS. DIAGNOSTICO POR IMAGEM; ESTUDOS RETROSPECTIVOS